VIENNA, Austria and COPENHAGEN, Denmark, Sept. 3, 2025 -- Speech Processing Solutions (SPS), the global leader behind Philips SpeechLive, today announced a strategic partnership with Corti, the specialized AI infrastructure company for healthcare, to introduce ambient clinical documentation directly into the SpeechLive platform. This partnership integrates Corti's real-time medical reasoning engine into the SpeechLive AI Assistant - transforming the trusted dictation platform into a fully AI-powered documentation ecosystem. As the only platform that brings together dictation, s
SEOUL, South Korea, Sept. 3, 2025 -- This is an article published in The Korea Herald: The Ministry of Food and Drug Safety announced Wednesday that it kicked off Global Bio Conference 2025, under the theme "Bio, Navigating Infinite Possibilities." The conference will be held from Wednesday to Friday at the Grand InterContinental Seoul Parnas in southern Seoul. Celebrating its 11th year, GBC has established itself as a leading global platform, bringing together approximately 5,000 participants each year from regulatory authorities, the pharmaceutical industry a
Editor's Summary Integration with NVIDIA Omniverse libraries via OpenXR runtime supports enhanced spatial awareness for industrial designs and simulations Partnership with Video Engineering brings 3D stereo microscopy to inspection, design, and prototyping workflows Collaboration with Smart Surgery for medical training allows for high-resolution, glasses-free analysis on SpatialLabs' 3D displays BERLIN, Sept. 3, 2025 -- Acer today announced significant advancements in its SpatialLabs™ Pro solution, unveiling new integrations with NVIDIA Omniverse, Video Engineer
BERLIN, Sept. 3, 2025 -- Acer Medical, an Acer Group company specializing in medical imaging and AI-powered healthcare solutions, unveiled aiMed, its next-generation generative AI medical documentation system at the next@acer global press conference, ahead of IFA 2025 in Berlin. The milestone underscores Acer Medical's expanding global footprint and its commitment to transforming healthcare through AI and digital innovation. aiMed directly addresses one of the most pressing challenges in modern healthcare —clinical documentation overload. On average, healthcare providers spend up to 25
SYDNEY, Sept. 2, 2025 -- Smartee Denti-Technology, a global leader in innovative clear aligner solutions, has officially launched its clear aligner products for children and teenagers in Australia. The product lines include Smartee Kinder and Smartee Teen, are designed to address the unique orthodontic challenges of growing patients at different developmental stages. Market Insights: Pediatric Orthodontics in Australia In Australia, pediatric orthodontic care is delivered through three main practitioner groups: orthodontic specialists, pediatric dentists, and general pra
SEOUL, South Korea, Sept. 3, 2025 -- DeepQure, a company pioneering a paradigm shift in hypertension treatment, today announced the appointment of Jason G. Jones as Global Vice President of Clinical & Regulatory Affairs. Jason joins DeepQure from SoniVie, an Israeli company developing catheter-based intravascular ultrasound renal denervation (RDN) treatment that was acquired by Boston Scientific for $540 million in March 2025. At SoniVie, he led the global clinical development strategy and clinical operations activities at the company. Jason oversaw the completion of enrollment for
ADELAIDE, Australia, Sept. 3, 2025 -- Fleet Space Technologies, Australia's leading space exploration company, and Australia's F1 Academy phenom, Joanne Ciconte, announced a brand partnership to elevate Australian women fearlessly driving innovation in high-performance STEM fields. Connecting two of Australia's leading pioneers in space exploration and motorsports, this partnership aims to highlight the rise of women leaders in high-performance STEM fields and how real-time data is fueling rapid advances in aerospace, exploration, and motorsport technology. “All Systems Go”
SHANGHAI and JERSEY CITY, N.J., Sept. 2, 2025 -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the US Food and Drug Administration (FDA) has approved BILDYOS® (denosumab-nxxp) injection 60 mg/mL and BILPREVDA® (denosumab-nxxp) injection 120 mg/1.7 mL, biosimilars to PROLIA (denosumab) and XGEVA (denosumab), respectively, for all indications of the reference products.1,2 "The FDA approvals of BILDYOS and BILPREVDA mark a significant step toward expanding access to critical bone care treatments needed by millions of people in the US, inclu
- The program focuses on antibiotic resistance in urinary tract infections (UTI-DR), with applications open until November 20; final awardees to be announced in August 2026- Selected researchers will receive up to USD 600,000 in research funding, along with access to Seegene's syndromic PCR assays, instruments, and software- Program aims to advance Seegene's Technology-Sharing Initiative and expand access to molecular diagnostics SEOUL, South Korea, Sept. 2, 2025 -- Seegene Inc., a global leader in molecular diagnostics, announced today the launch of the 20
Neurophet's AI-based brain imaging analysis solutions to support global standardization of Alzheimer's and other dementia-related data Enhancing dementia research by integrating AI imaging solutions with real-world data platforms SEOUL, South Korea, Sept. 2, 2025 -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced today that it has signed a Memorandum of Understanding (MoU) with the International Registry for Alzheimer's Disease and Other Dementias Foundation (I